Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
ACMA Appoints ENGINE to Develop Australia's First National Gambling Self-Exclusion Register 2021-07-08 07:00
Australian Fintech Launches Hay-as-a-Service, Managed by Appian Low-Code Automation Platform 2021-07-08 07:00
ShipBob Launches First Australia-Based Fulfillment Center in Melbourne 2021-07-07 20:00
Near Bolsters Australia-New Zealand Leadership Team With Key Executive Hires 2021-07-07 07:00
Integrated Media Technology Limited Announces Registered Direct Offering of Ordinary Shares 2021-07-06 23:00
Bionomics Initiates Phase 2b ATTUNE Study of BNC210 in PTSD 2021-07-06 18:00
Equisoft continues global expansion with U.K. acquisition of investment and pension management solutions provider Altus 2021-07-06 11:30
Love Your Body. Change Your World. USANA Proudly Launches New Product Line 2021-07-05 07:13
Pallas Capital Drives Operational Efficiencies with Nintex Promapp® 2021-07-05 07:05
Alterity Therapeutics granted a new US patent targeting major neurodegenerative diseases including Alzheimer's and Parkinson's 2021-07-01 19:50
Randstad RiseSmart Receives 2021 Great Place to Work® Certification 2021-07-01 07:00
ENGINE Media Exchange Appoints Alex Cook New South Wales Sales Director 2021-07-01 07:00
Kazia Provides Progress Update on Paxalisib and EVT801 Clinical Programs 2021-06-30 22:00
LyondellBasell announces acquisition of PolyPacific Polymers Sdn. Bhd. in Malaysia 2021-06-30 15:00
Nintex Announces Finalists of the 2021 Nintex Partner Awards 2021-06-30 07:07
Webprofits to aggressively drive Airtasker's UK growth plan 2021-06-28 23:12
International experts join Microba Life Sciences inaugural IBD Advisory Panel 2021-06-28 21:00
'Cloud-change' for Abacus Property Group as it moves all lease data online with MRI™ Contract Intelligence 2021-06-25 11:38
Majority of APJ Financial Services Firms Say Automation Delivers Competitive Advantage 2021-06-24 07:00
Alterity Therapeutics Limited Received European Union Regulatory Guidance for ATH434 Phase 2 Clinical Trial 2021-06-23 21:21
1 33 34 35 36 37 113